Claire Paquet
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 230 publications
Anti-amyloid immunotherapies in Alzheimer's disease: Are future prescribers prepared? Insights of a French national survey.
Journal: Journal of Alzheimer's disease : JAD
Published: June 04, 2026
Tanycytic degeneration impairs tau clearance and contributes to Alzheimer's disease pathology.
Journal: Cell press blue
Published: May 25, 2026
Plasma and CSF adiponectin levels in biomarker-confirmed Alzheimer's disease: A cross-sectional study in a tertiary memory clinic.
Journal: Metabolic brain disease
Published: May 14, 2026
Eligibility for lecanemab treatment in a French memory clinic setting.
Journal: Journal of neurology
Published: January 09, 2026
Longitudinal Study of Plasma NFL and GFAP as Biomarkers of Alcohol Withdrawal-Associated Brain Injury.
Journal: Addiction biology
Published: December 31, 2025
Do sex differences in dementia with Lewy bodies arise from Alzheimer's disease biological profile?
Journal: Journal of Alzheimer's disease : JAD
Published: December 29, 2025
Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progression.
Journal: Molecular psychiatry
Published: December 21, 2025
Physical activity attenuates the association between allostatic load and early Alzheimer's disease-related biomarkers in older adults.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: December 15, 2025
Clinical correlates of sleep profiles in dementia with Lewy bodies: a latent class approach.
Journal: Alzheimer's research & therapy
Published: December 08, 2025
Assessment of medication-related risks for mortality prediction in Alzheimer's disease.
Journal: Maturitas
Published: December 04, 2025
Association of Alzheimer's disease biomarkers with malnutrition and altered body composition in cognitively impaired patients: a cross-sectional memory clinic study.
Journal: Alzheimer's research & therapy
Published: October 29, 2025
Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies.
Journal: Journal of Alzheimer's disease : JAD
Published: October 22, 2025
Last Updated: 09/26/2026